Suppr超能文献

东南亚国家局限性前列腺癌的生存率和预后因素:系统评价与荟萃分析。

Survival Rate and Prognostic Factors of Localised Prostate Cancer in Southeast Asian Countries: A Systematic Review with Meta-Analysis.

机构信息

Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia.

出版信息

Asian Pac J Cancer Prev. 2023 Sep 1;24(9):2941-2095. doi: 10.31557/APJCP.2023.24.9.2941.

Abstract

UNLABELLED

Prostate cancer (Pca) is one of the most prevalent health conditions affecting men, particularly older men, and cases have increased in recent years.

OBJECTIVE

This review examined the survival rate and prognostic factors of patients with Pca in Southeast Asia (SEA).

METHODS

We conducted a systematic search of three databases (PubMed, Scopus, Web of Science) and a manual search until April 1, 2022. The selected papers were evaluated using the Newcastle-Ottawa Quality Assessment Form for Cohort Studies. The review protocol was registered with PROSPERO (CRD42022326521). Pooled prevalence rates were calculated using the programme R version 4.2.1. Heterogeneity was assessed using the I2 statistic and p-value. A narrative approach was used to describe prognostic factors. Studies were selected and finalised based on the review question. The quality of the included studies was assessed.

RESULTS

A total of 11 studies were included in this review. The 1-, 3-, 5- and 10-year survival rates of SEA Pca cases were 80.8%, 51.9%, 66.1% (range 32.1-100) and 78% (range 55.9-100), respectively. Prognostic factors for Pca were discussed in terms of sociodemographic, disease-related and treatment-related aspects. The predictors of significantly lower survival were age more than 75 years, cancer detected during transurethral resection of the prostate, Gleason score more or equal to eight, high-risk group, metastases and no adjuvant radiotherapy. A meta-analysis on the pooled HR of prostate cancer could not be performed due to the heterogeneity of prognostic factors. The pooled prevalence of localised and metastatic prostate cancer in SEA countries was 39% 95% CI [20-62] and 40% 95% CI [28-53], respectively.

CONCLUSION

The survival rate in SEA countries can be determined by prognostic factors, which can be divided into sociodemographic, disease-related and treatment-related factors. Therefore, further studies are needed to improve the understanding and treatment of Pca in the region SEA.

摘要

未加标签

前列腺癌(Pca)是影响男性,尤其是老年男性的最常见健康问题之一,近年来病例有所增加。

目的

本综述检查了东南亚(SEA)前列腺癌患者的生存率和预后因素。

方法

我们对三个数据库(PubMed、Scopus、Web of Science)进行了系统检索,并进行了手动检索,直到 2022 年 4 月 1 日。使用纽卡斯尔-渥太华质量评估表对队列研究进行了评估。审查方案在 PROSPERO(CRD42022326521)上进行了注册。使用程序 R 版本 4.2.1 计算了汇总患病率。使用 I2 统计量和 p 值评估异质性。采用叙述方法描述预后因素。根据审查问题选择和最终确定研究。评估了纳入研究的质量。

结果

本综述共纳入 11 项研究。SEA Pca 病例的 1、3、5 和 10 年生存率分别为 80.8%、51.9%、66.1%(范围 32.1-100)和 78%(范围 55.9-100)。讨论了前列腺癌的预后因素,涉及社会人口统计学、疾病相关和治疗相关方面。年龄超过 75 岁、经尿道前列腺切除术时发现癌症、Gleason 评分≥8、高危组、转移和无辅助放疗是生存率显著降低的预测因素。由于预后因素的异质性,无法对前列腺癌的合并 HR 进行 meta 分析。SEA 国家局限性和转移性前列腺癌的汇总患病率分别为 39%(95%CI [20-62])和 40%(95%CI [28-53])。

结论

SEA 国家的生存率可由预后因素决定,可分为社会人口统计学、疾病相关和治疗相关因素。因此,需要进一步研究以提高对该地区前列腺癌的认识和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17aa/10762736/ba11c1edd942/APJCP-24-2941-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验